Photo via NPR

A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened?

Read the original at NPR ↗
Cite

Lupkin, S. (2026, September 17). A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened? NPR. https://www.npr.org/2026/09/17/nx-s1-5971066/trump-rx-medicaid-generous-drug-prices-pfizer-favored-nation

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

NPR · collected 2026-09-17 · by Sydney Lupkin

Quick Summary

President Trump announced a year ago that pharmaceutical company Pfizer would offer its medications at reduced prices for Medicaid recipients. However, despite his claims of significant progress in lowering drug costs, implementation has been slow and unclear. While 26 companies signed agreements with the White House, these details have not been made public, and it remains uncertain whether all drugs from participating companies will actually be discounted under Medicaid. The lack of transparency and voluntary participation by both states and pharmaceutical firms complicates the realization of Trump's promises to reduce Medicaid drug costs significantly.
Written by AI on 2026-09-17, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

A year ago, President Trump pledged to lower Medicaid drug prices by negotiating deals with pharmaceutical companies. On September 30, 2018, he announced an agreement with Pfizer, claiming it would be the first of many such agreements that would bring U.S. drug prices in line with other wealthy countries. The White House stated that eventually, 26 companies signed similar deals, though these have not been made public. Despite his claims during a speech at the Republican National Convention on September 10, Trump's actual impact on lowering prescription drug costs remains unclear as the agreements and their effects are not widely known or available for scrutiny.

Written for “Medicaid Drug Prices Policy” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Medicaid Drug Prices Policy
Politics · 1 article(s) covering the same event.

Compared with similar articles

This article reads leans left and hedges 22% of its claims. Each row says how that neighbour differs.
Washington Examiner
⚖️ Leans left Hedges 0 of 2 claims Outlet record 70/100
“Article A discusses past pledges made by President Trump a year ago, while Article B reports on an upcoming announcement related to Medicaid reform scheduled for the near future.”
Toronto Star
⚖️ Leans left Hedges 2 of 3 claims Outlet record 64/100
“While both articles discuss President Trump's efforts to lower Medicaid drug prices, they refer to different specific announcements or timeframes.”
ABC News (US)
⚖️ Leans left Hedges 6 of 20 claims Outlet record 70/100
“While both articles discuss President Trump's efforts to lower Medicaid drug prices, Article A focuses on a pledge made a year ago and its outcome, while Article B reports on an upcoming announcement of all states joining the program, indicating different specific events.”
Semafor
⚖️ Leans strongly left further left than this Hedges 1 of 9 claims Outlet record 59/100
“While both articles discuss President Trump's efforts to lower drug prices, they describe different aspects of the initiative—one focusing on the pledge and its anniversary, the other on health experts questioning the program's effectiveness.”
Semafor
Hedges 1 of 6 claims Outlet record 59/100
“The articles discuss different times - one year ago's pledge and current progress announcement.”
Washington Examiner
⚖️ Leans left Hedges 0 of 10 claims Outlet record 70/100
“Article A discusses Trump's pledge a year ago and asks if it has been fulfilled, while Article B reports on an announcement expected from the White House regarding Medicaid drug prices. These appear to be different points in time or different aspects of related events.”
New York Post
Hedges 0 of 14 claims Outlet record 66/100
“Article A discusses a pledge made by President Trump about lowering Medicaid drug prices, while Article B reports on all 50 states opting into a 'most favored nations' drug pricing initiative announced by Trump.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
54
sentences that state something as happening or true
Uncertain
22%
12 of 54 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
60/100
NPR's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-17 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

NPR · 1023 article(s) · 3 correction(s) detected
Running correction rate · 3 correction(s)

Who wrote this

Sydney Lupkin
3 article(s) here · 1 carrying a prediction
🔮 "She would always go get my high heels from the closet and clop around in those — which she scared us to death," says her mom, Cara O'Neill, a pediatrician in Columbia, S.C. But by the time Eliza turned 3, her parents noticed she was falling behind on developmental milestones.
🔮 Trump administration will allow pharmacies to make popular peptides Unproven but popular peptides touted for wellness have been available on the gray market, despite an official ban.
🔮 Last year on Sept. 30, the president and his health officials gathered in the Oval Office to announce a major agreement with Pfizer — the first of what he said would be a series of deals with pharmaceutical companies.
Also by Sydney Lupkin
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Americans Medicaid NPR Pfizer Republican National Convention

Subjects

Medicaid ORG · 10× Trump PERSON · 7× NPR ORG · 6× Pfizer ORG · 3× Americans NORP · 2× Dallas GPE · 1× KFF ORG · 1× TrumpRx ORG · 1× U.S. GPE · 1× the White House GPE · 1×

Narrative

"We went from the highest prescription drug prices, by far, anywhere in the world, to the lowest prescription drug prices anywhere in the world," Trump said during his remarks at the midterm Republican National Convention in Dallas on Sept 10.
framing: mixed · carried by 1 article(s) · first seen 2026-09-17
🔮 Last year on Sept. 30, the president and his health officials gathered in the Oval Office to announce a major agreement with Pfizer — the first of what he said would be a series of deals with pharmaceutical companies.

Claims (54 extracted, 12 hedged)

A year ago, President Trump pledged to lower Medicaid drug prices. asserted
Trump → pledge → prices
Has that happened? asserted
that → happen → ?
When President Trump talks about accomplishments of his second term, he often mentions the deals he's struck with pharmaceutical companies to lower drug prices. asserted
he → talk → prices
"We went from the highest prescription drug prices, by far, anywhere in the world, to the lowest prescription drug prices anywhere in the world," Trump said during his remarks at the midterm Republican National Convention in Dallas on Sept 10. asserted
Trump → go → Sept
"And that alone should get us a big victory in our midterms that are coming up." asserted
that → get → midterms
Last year on Sept. 30, the president and his health officials gathered in the Oval Office to announce a major agreement with Pfizer — the first of what he said would be a series of deals with pharmaceutical companies. asserted
he → gather → companies
Eventually, the White House said 26 companies signed agreements, but they have not been made public. asserted
they → say → agreements
Trump refers to these agreements as "most favored nation" deals, meant to bring U.S. drug prices in line with what other wealthy countries pay for drugs. asserted
countries → refer → drugs
The most buzzed-about part of the first announcement was the creation of TrumpRx, a website for consumers to find discounts on some drugs if they choose not to use their health insurance. asserted
they → buzz → insurance
But, as NPR has reported, the drugs available are limited, and most consumers will get a better price if they just use their insurance and pay the copay. asserted
they → report → copay
But Trump's announcement also included another promise, for the low-income and disabled Americans who are covered by Medicaid: "Today Pfizer is committing to offer all of their prescription medications to Medicaid," he said on Sept. 30, 2025. asserted
he → include → Sept.
It's gonna have a huge impact on bringing Medicaid costs down like nothing else. asserted
It → go → nothing
And Trump said he expected other drug companies would do the same. asserted
companies → say → same
Medicaid covers 66 million Americans, and its net spending on prescription drugs grew by 46% between 2019 and 2024, costing taxpayers $46 billion dollars that year, according to the nonpartisan health policy research group KFF. uncertain
spending → cover → group
But turning Trump's promises into an operational program has been difficult. asserted
turning → turn → program
A year later, that effort has been plagued by uncertainties, delays and a general lack of transparency. asserted
effort → plague → transparency
The pilot program relies on voluntary participation, by both drug companies and individual states, which means the number of drugs that will be discounted, and the number of patients who will have access to those prices, could be lower than what Trump originally promised. uncertain
Trump → rely → what
Companies might not offer all of their drugs Because the administration has refused to release the actual pharmaceutical agreements, it's not clear if participating companies have to offer Medicaid most-favored nation discounts for all their drugs. uncertain
companies → offer → drugs
NPR reached out to Pfizer and 16 other major drug companies that struck pricing deals with the Trump Administration over the past year. asserted
that → reach → year
None would confirm to NPR that all of their drugs would be discounted in Medicaid, or say exactly which ones would be discounted. asserted
ones → confirm → Medicaid
Gilead told NPR it is working with states to make "selected covered products available," including drugs that treat hepatitis C, hepatitis B and HIV. asserted
that → tell → C
Sanofi said it would make the discounted pricing available for "certain wholly owned medicines that treat diabetes, cardiovascular and neurological conditions, and cancer." asserted
that → say → diabetes
Eli Lilly said it didn't have a final list but expected "many" of its medicines to be part of the pilot program at a discount. asserted
many → say → discount
It said "any" of its "eligible covered outpatient drugs " could be selected — except for its GLP-1 medicines that are part of another pilot program in Medicare. uncertain
that → say → Medicare
Genentech would only say that "certain medicines" would be a part of the Medicaid program. asserted
medicines → say → program
Two companies told NPR the terms of the Medicaid agreements were confidential. asserted
terms → tell → agreements
The federal regulatory agency, the Centers for Medicare and Medicaid, wouldn't tell NPR how many of each company's drugs would get Medicaid discounts either. asserted
many → tell → discounts
This fact that companies aren't discounting all of their drugs as part of this pilot program is worrisome, said Dr. Thomas Hwang of Brigham and Women's Hospital in Boston. asserted
Hwang → discount → Boston
It makes it easier for companies to game the system, he said " asserted
he → make → system
Companies have every incentive to cherry-pick [for this program] the products for which they already give Medicaid the best discounts and for which the international price may not be that much lower," Hwang said. uncertain
Hwang → have → which
In other words, the companies might publicly get credit for discounts that are actually negligible. uncertain
that → get → discounts
"So there would be an incentive for companies to try to limit their liability and pay less to Medicaid," Hwang explained. asserted
Hwang → try → Medicaid
"That gaming is what worries me about this backsliding over the past months — from the initial messaging that all drugs will be offered from participating manufacturers, and now to maybe only certain drugs will be offered. asserted
drugs → worry → offered
The discounts won't reach all states Even if pharmaceutical companies do end up offering lower prices on a wide range of products, those new prices won't simply take effect nationwide. asserted
prices → reach → effect
Instead, the discount program is being set up as a voluntary pilot. asserted
program → set → pilot
That means every state has to decide whether to opt-in, and then agree to certain conditions. asserted
state → mean → conditions
The pilot is called the Generous model. asserted
pilot → call → ?
Deadlines for drug companies and states to sign up were originally set for the spring and summer, but they've been pushed back. asserted
they → sign → spring
"It's always a bad sign when you keep pushing back your deadline," said Ameet Sarpatwari, a professor of population medicine at Harvard, and a drug policy researcher. asserted
Sarpatwari → keep → Harvard
Why states might hesitate to commit Even though the aim of the Generous pilot program is lower drug prices, a state that signs up could be exposing itself to some financial risks. uncertain
that → hesitate → risks
…and 14 more, not listed.
💬Give feedback
🕘History 🎫Support